NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) Short Interest Update

NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) saw a large decrease in short interest in the month of October. As of October 31st, there was short interest totalling 1,500 shares, a decrease of 71.2% from the October 15th total of 5,200 shares. Based on an average daily trading volume, of 3,400 shares, the days-to-cover ratio is currently 0.4 days.

NRx Pharmaceuticals Trading Down 10.1 %

Shares of NRx Pharmaceuticals stock traded down $0.01 during trading on Wednesday, hitting $0.08. 1,100 shares of the company’s stock were exchanged, compared to its average volume of 16,140. The business has a 50-day simple moving average of $0.06 and a 200-day simple moving average of $0.07. NRx Pharmaceuticals has a 52-week low of $0.04 and a 52-week high of $0.39.

About NRx Pharmaceuticals

NRx Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned FDA-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior.